$HSIC (Henry Schein, Inc.)

$HSIC {{ '2016-08-04T17:40:48+0000' | timeago}} • Webcast

$HSIC said that dental sales in North America were slightly below the company's expectations in 2Q16. Sales in medical, animal health, technology, value-added services verticals were strong. With regards to the Brexit impact, $HSIC believes that UK and Europe represent attractive long-term opportunities for its dental and animal health businesses.

$HSIC {{ '2017-06-28T12:03:39+0000' | timeago}} • Announcement

$HSIC extended its existing agreement in Canada with $XRAY to include the CEREC CAD/CAM restoration system and the Schick line of imaging sensors. Henry Schein Canada will represent the entire $XRAY product line, effective Sept. 1, 2017. The revised agreement is expected to be neutral to $HSIC EPS in 2017 and accretive thereafter.

$HSIC {{ '2017-06-27T20:45:25+0000' | timeago}} • Announcement

$HSIC settled litigation with SourceOne Dental Inc. that will result in a $0.04 per share charge when the company reports its 2Q17 results. The company denies any wrongdoing related to the SourceOne litigation and chose to pursue a settlement solely to avoid further distraction and cost resulting from this matter.

$HSIC {{ '2017-05-09T15:05:15+0000' | timeago}} • Webcast

$HSIC believes the market for implants is growing strongly throughout the world. Implants grew mid-single digits worldwide with good growth in the US. Europe is a bit muted while the developing world is growing significantly. The investments by specialists in digital technology is driving equipment sales throughout the world.

$HSIC {{ '2017-05-09T14:52:21+0000' | timeago}} • Webcast

$HSIC does not see much change in its go-to-market strategy. The company has been building its digital technology and capacity for the last 4-5 years. The goal is to provide the best comprehensive solution to dentists. $HSIC has invested heavily in its practice solutions software. $HSIC will continue to add more resources and expand its offerings.

$HSIC {{ '2017-05-09T12:18:37+0000' | timeago}} • Announcement

$HSIC afffirmed its 2017 EPS guidance of $7.17-7.30. This guidance reflects growth of 16-18% compared with 2016 EPS of $6.19, and growth of 8-10% compared with 2016 non-GAAP EPS of $6.61. The company noted that FY17 includes one less week than FY16.

$HSIC {{ '2017-05-09T12:16:27+0000' | timeago}} • Announcement

$HSIC reported a rise in 1Q17 earnings driven by higher sales. Net income rose to $140.75MM or $1.76 per share from $113.75MM or $1.37 per share last year. Net sales grew to $2.92Bil from $2.71Bil, on 8.7% growth in local currencies and a 1.0% decline related to foreign currency exchange.

$XRAY {{ '2017-05-09T11:11:53+0000' | timeago}} • Announcement

$XRAY announced a new distribution agreement with $PDCO, continuing its partnership over many years. Additionally, $XRAY announced a new three-year agreement with $HSIC, effective September 1, 2017 to distribute $XRAY's full line of dental equipment in the US.

$HSIC {{ '2017-05-02T14:40:25+0000' | timeago}} • Announcement

$HSIC, a provider of health care products and services, has completed its acquisition of Southern Anesthesia Surgical, a distributor of anesthesia and surgical supplies. The transaction was announced on February 20, 2017. Financial terms of the transaction were not disclosed.

$HSIC {{ '2017-05-02T14:21:43+0000' | timeago}} • Announcement

$HSIC completed acquisition of Southern Anesthesia Surgical (SAS), a U.S. distributor of anesthesia and surgical supplies to oral surgeons, dental anesthesiologists, and periodontists. The SAS business will continue to be led by its current management team, including Bill Alexander, VP and General Manager.

$HSIC {{ '2017-04-19T12:44:45+0000' | timeago}} • Announcement

$HSIC amended its revolving credit facility, including an increase in the maximum borrowing amount from $500MM to $750MM, and an extension of the facility through September 2022. JP Morgan Securities LLC and U.S. Bank NA served as Joint Lead Arrangers for the new facility.

$HSIC {{ '2017-02-22T15:04:47+0000' | timeago}} • Announcement

Henry Schein Medical, an $HSIC company, signed an exclusive distribution agreement with Rijuven, which develops innovative digital medical devices, to sell its CardioSleeve diagnostic device to medical practitioners.

$HSIC {{ '2017-02-21T19:18:26+0000' | timeago}} • Webcast

The global animal health market is healthy and growing, particularly in the companion animal segment, where $HSIC has expanded opportunities to deliver value-added solutions. The company continued to gain market share in 4Q16. $HSIC is well-positioned to leverage attractive opportunities in the animal health markets.

$HSIC {{ '2017-02-21T19:04:59+0000' | timeago}} • Webcast

During 4Q16, $HSIC repurchased approx. 1.3MM shares at an average price of $156.10 per share or approx. $200MM. For full-year 2016, the company repurchased $550MM of its stock representing 3.5MM shares at an average price of $158.88 per share. Capex for 2016 was $70.2MM.

$HSIC {{ '2017-02-21T18:56:03+0000' | timeago}} • Webcast

In $HSIC’s Dental segment, North American internal growth in local currency was 2.2% in 4Q16 and included 1.9% growth in sales of dental consumable merchandise and 2.7% growth in dental equipment sales and services revenue.

$HSIC {{ '2017-02-21T15:35:29+0000' | timeago}} • Announcement

$HSIC agreed to buy Southern Anesthesia Surgical (SAS), a leading U.S. distributor of anesthesia and surgical supplies to oral surgeons, dental anesthesiologists, and periodontists, for undisclosed terms. The agreement is expected to close in 2Q17. SAS will become part of ACE Surgical Supply Co., Inc. (ACE), a subsidiary of $HSIC.

$HSIC {{ '2017-02-21T12:26:51+0000' | timeago}} • Announcement

$HSIC affirms FY17 guidance. The company expects its diluted EPS to be in the range of $7.17-7.30, representing 16-18% growth from FY16.

$HSIC {{ '2017-02-21T12:24:29+0000' | timeago}} • Announcement

During 4Q16, $HSIC's Dental segment sales rose 7.7% to $1.5Bil. The company's Animal Health segment sales rose 10.8% to $837.8MM and Medical segment sales rose 10.6% to $621MM. $HSIC reported 19.6% rise in its Technology and Value-Added Services segment sales to $112.2MM.

$HSIC {{ '2017-02-21T12:20:14+0000' | timeago}} • Announcement

Healthcare products company $HSIC reported 7% increase in its 4Q16 earnings, helped by increase in net sales. The company's net earnings rose to $139.2MM from $129.9MM during 4Q16. Diluted EPS rose 10.9% to $1.73 from $1.56 during prior year quarter. Net sales jumped 9.5% YoY to $3.1Bil. Excluding items, $HSIC earned $1.88 per share.

$HSIC {{ '2017-02-09T16:48:25+0000' | timeago}} • Announcement

$HSIC appointed Bridget Ross as President, Global Medical Group. Ross will join $HSIC from $JNJ, where she spent more than 28 years in sales, marketing and general management roles. At $HSIC, she will serve as a member of its Executive Management Committee (EMC). Ross's appointment is effective Feb. 14, 2017.

$HSIC {{ '2017-01-23T14:53:43+0000' | timeago}} • Announcement

Melville, NY-based medical product distributor $HSIC enters into Brazilian animal health market with a 51% ownership investment in Tecnew.

Recent Transcripts

ISRG (Intuitive Surgical, Inc.)
Thursday, July 20 2017 - 8:30pm
ABT (Abbott Laboratories)
Thursday, July 20 2017 - 1:00pm
UNH (UnitedHealth Group Incorporated)
Tuesday, July 18 2017 - 12:45pm
ENZ (Enzo Biochem Inc.)
Friday, June 9 2017 - 12:30pm
PLUS (ePlus inc.)
Wednesday, May 24 2017 - 8:30pm
MCK (McKesson Corporation)
Thursday, May 18 2017 - 9:00pm
HOLX (Hologic Inc.)
Wednesday, May 10 2017 - 8:30pm
ACAD (ACADIA Pharmaceuticals Inc.)
Tuesday, May 9 2017 - 9:00pm
HSIC (Henry Schein, Inc.)
Tuesday, May 9 2017 - 2:00pm
STE (Steris Plc)
Tuesday, May 9 2017 - 2:00pm
CI (Cigna Corp.)
Friday, May 5 2017 - 12:30pm
MOH (Molina Healthcare, Inc.)
Thursday, May 4 2017 - 9:00pm
SYN (Synthetic Biologics Inc.)
Thursday, May 4 2017 - 8:30pm
Thursday, May 4 2017 - 2:00pm
ABC (AmerisourceBergen Corporation)
Thursday, May 4 2017 - 12:30pm
HUM (Humana Inc.)
Wednesday, May 3 2017 - 1:00pm
OMI (Owens & Minor Inc.)
Wednesday, May 3 2017 - 12:30pm
WCG (WellCare Health Plans, Inc.)
Wednesday, May 3 2017 - 12:00pm
HSKA (Heska Corporation)
Tuesday, May 2 2017 - 3:00pm
IDXX (IDEXX Laboratories, Inc.)
Friday, April 28 2017 - 12:30pm

AlphaGraphics you may like